Company · CIK 1736730
Camp4 Therapeutics Corp
| CIK | 1736730 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | MA |
| Listed | CAMP (Nasdaq) |
| First annual or quarterly report | 2024-11-21 |
Offerings
4 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-298067 | 2026-08-06 | 2026-08-12 | 2 | |
| 333-291432 | 2025-11-10 | 2025-12-18 | 3 | |
| 333-291225 | 2025-11-03 | 2025-11-03 | 1 | |
| 333-282241 | 2024-09-20 | 2024-10-11 | 5 |
Filings
12| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-08-12 | EFFECTDeclared effective | 333-298067 | 9999999995-26-002650 |
| 2026-08-06 | S-3Shelf registered | 333-298067 | 0001628280-26-054389 |
| 2025-12-18 | 424B5Shelf takedown | 333-291432 | 0001628280-25-058007 |
| 2025-12-01 | 424B5Shelf takedown | 333-291432 | 0001628280-25-054439 |
| 2025-11-10 | S-3Shelf registered | 333-291432 | 0001736730-25-000098 |
| 2025-11-03 | S-3Shelf registered | 333-291225 | 0001736730-25-000086 |
| 2024-10-11 | 424B4Final prospectus | 333-282241 | 0001104659-24-108067 |
| 2024-10-10 | EFFECTDeclared effective | 333-282241 | 9999999995-24-003151 |
| 2024-10-07 | S-1/AAmendment | 333-282241 | 0001104659-24-106393 |
| 2024-09-26 | S-1/AAmendment | 333-282241 | 0001104659-24-103141 |
| 2024-09-20 | S-1Registration filed | 333-282241 | 0001104659-24-101618 |
| 2024-06-14 | DRSDraft made public | 377-07276 | 0001104659-24-071596 |